{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:59:43Z","timestamp":1789736383397,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Royan Institutes"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neuroscience.2015.10.013","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:32:23Z","timestamp":1445560343000},"page":"34-44","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720)"],"prefix":"10.1016","volume":"311","author":[{"given":"A.","family":"Yazdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Baharvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Javan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2015.10.013_b0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/1352458511400476","article-title":"Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis","volume":"17","author":"Al-Izki","year":"2011","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.brainresbull.2007.06.023","article-title":"FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis","volume":"74","author":"Balatoni","year":"2007","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/glia.10159","article-title":"Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis","volume":"41","author":"Ben-Hur","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Dis"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0030","first-page":"213","article-title":"A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya)","volume":"12","author":"Chun","year":"2011","journal-title":"Dis Med"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2000.tb06543.x","article-title":"Neurobiology of receptor-mediated lysophospholipid signaling: from the first lysophospholipid receptor to roles in nervous system function and development","volume":"905","author":"Chun","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod\u2019s efficacy and adverse effects in multiple sclerosis","volume":"69","author":"Cohen","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lfs.2014.12.007","article-title":"Exogenous Oct4 in combination with valproic acid increased neural progenitor markers: an approach for enhancing the repair potential of the brain","volume":"122","author":"Dehghan","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-510X(00)00331-2","article-title":"In vivo evaluation of remyelination in rat brain by magnetization transfer imaging","volume":"178","author":"Deloire-Grassin","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mcn.2004.06.015","article-title":"Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS","volume":"27","author":"Fancy","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"(Multiple sclerosis\u2014the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/DDDT.S8927","article-title":"Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach","volume":"6","author":"Gasperini","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.21289","article-title":"Toward the development of rational therapies in multiple sclerosis: what is on the horizon?","volume":"62","author":"Hemmer","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mcn.2011.06.007","article-title":"Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo","volume":"48","author":"Hu","year":"2011","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0090","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0408258102","article-title":"Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1\u03b1\/CXC chemokine receptor 4 pathway","volume":"101","author":"Imitola","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0095","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1523\/JNEUROSCI.4645-04.2005","article-title":"Edg8\/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival","volume":"25","author":"Jaillard","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0100","unstructured":"Jung C, Miron V, Cook S, Foster C, Antel J, Soliven B (2006) Pleiotropic actions of FTY720-phosphate in cells of oligodendroglial lineage. In: Multiple sclerosis (vol. 12, pp S100\u2013S101) Sage Publications Ltd."},{"key":"10.1016\/j.neuroscience.2015.10.013_b0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/01.TP.0000084822.01372.AC","article-title":"Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study","volume":"76","author":"Kahan","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0115","first-page":"439","article-title":"FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration","volume":"2","author":"Kataoka","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0120","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1096\/fj.10-173203","article-title":"Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model","volume":"25","author":"Kim","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/stemcells.2006-0223","article-title":"Essential roles of sphingosine 1-phosphate\/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury","volume":"25","author":"Kimura","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1352458512438723","article-title":"FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination","volume":"18","author":"Kipp","year":"2012","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-5-39","article-title":"Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats","volume":"5","author":"Mann","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0140","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.wnl.0000327609.57688.ea","article-title":"FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis","volume":"71","author":"Mehling","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ana.21227","article-title":"FTY720 modulates human oligodendrocyte progenitor process extension and survival","volume":"63","author":"Miron","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0150","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2353\/ajpath.2010.091234","article-title":"Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices","volume":"176","author":"Miron","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/10409238.2010.522975","article-title":"Roles for lysophospholipid S1P receptors in multiple sclerosis","volume":"46","author":"Noguchi","year":"2011","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0160","series-title":"The mouse brain in stereotactic coordinates: compact","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMct1101691","article-title":"Fingolimod for multiple sclerosis","volume":"366","author":"Pelletier","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.11.015","article-title":"Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis","volume":"184","author":"Peterson","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0175","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.4049\/jimmunol.164.11.5761","article-title":"FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory","volume":"164","author":"Pinschewer","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0180","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0185","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ajpath.2011.01.003","article-title":"Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis","volume":"178","author":"Rau","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0190","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1476-5381.2011.01579.x","article-title":"ral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis","volume":"165","author":"Rossi","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0195","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1073\/pnas.1200151109","article-title":"Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography","volume":"109","author":"Schregel","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bph.12938","article-title":"The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination","volume":"172","author":"Slowik","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0205","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.0b013e31820d9507","article-title":"The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators","volume":"76","author":"Soliven","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0210","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jnr.22335","article-title":"Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia","volume":"88","author":"Taylor","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1742-2094-8-143","article-title":"Differential aquaporin 4 expression during edema build-up and resolution phases of brain inflammation","volume":"8","author":"Tourdias","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0220","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Van Doorn","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0225","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.4049\/jimmunol.1100333","article-title":"Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis","volume":"187","author":"Wang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0230","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awf031","article-title":"Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord","volume":"125","author":"Wolswijk","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0235","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2353\/ajpath.2010.091203","article-title":"Evaluation of bone marrow-and brain-derived neural stem cells in therapy of central nervous system autoimmunity","volume":"177","author":"Yang","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0240","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/mt.2013.241","article-title":"Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells","volume":"22","author":"Yang","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.neuroscience.2015.10.013_b0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2015.01.006","article-title":"Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis","volume":"76","author":"Zhang","year":"2015","journal-title":"Neurobiol Dis"}],"updated-by":[{"DOI":"10.1016\/j.neuroscience.2021.04.020","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215009203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215009203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T23:20:46Z","timestamp":1748647246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452215009203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"alternative-id":["S0306452215009203"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2015.10.013","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}